{"acquisitions":[],"changes":[],"country":"US","description":"Lohocla develops multi-target small-molecule drugs aimed at chronic pain, neuroinflammation, and addiction by modulating several neural pathways with a single compound. It targets patients underserved by current single-mechanism therapies. The multi-target design is positioned to improve both efficacy and safety profiles.","domain":"lohocla.com","employees":null,"founded":2006,"fundingTotalQuarantined":false,"githubOrg":"lohocla","githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":39.740511,"lng":-104.830994,"location":"AURORA, Colorado","multiples":[],"name":"LOHOCLA RESEARCH CORPORATION","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":3417981,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"lohocla-com-2024-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"lohocla-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"lohocla.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://lohocla.com"},{"fact":"description","publisher":"lohocla.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://lohocla.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["PHP 8.4.19","Bootstrap 4.6.1","Apache HTTP Server","Google Analytics","Google Tag Manager","Popper 2.11.2","DoubleClick Floodlight","cdnjs","WordPress","Cloudflare","MySQL","jquery 1.9.1"],"totalRaisedUsd":3417981,"traction":[],"updatedAt":"2026-05-05","valuations":[]}